id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-313785-8tipkksu	d'Ettorre, Gabriella	Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19	2020-07-07		.txt	text/plain	3786	196	43	The patients evaluated in this study were hospitalized at the Department of Infectious Diseases, Policlinico Umberto Abbreviations: ABX, antibiotics; ALT, alanine aminotransferase; ALT, aspartate aminotransferase; CI, confidence interval; COVID-19, coronavIrus disease 19; CPAP, continuous positive airway pressure; ECMO, extracorporeal membrane oxygenation; FDR, False Discovery Rate; GLA, gut lung axis; Hb, hemoglobin; HCQ, hydroxychloroquine; HIV, Human immunodeficiency virus; HO-1, Heme oxygenase-1; ICU, Intensive Care Unit; IRQ, interquartile range; Nrf2, nuclear factor erythroid 2p45-related factor 2; OB-, oral bacteriotherapy not administered group; OB+, oral bacteriotherapy administered group; ROS, reactive oxygen species; SCFA, short chain fatty acids; TCZ, Tocilizumab. The observed partial pressure of arterial oxygen (PaO 2 ), the fraction of inspired oxygen FiO 2 , the disappearance of symptoms associated to COVID-19, adverse events, and the number of patients transferred to ICU were collected at 24 h, 48 h, 72 h, and 7 days from the start of oral bacteriotherapy and hospitalization for all the patients independently from the treatments.	./cache/cord-313785-8tipkksu.txt	./txt/cord-313785-8tipkksu.txt